[1] |
CHEN W,ZHENG R,BAADE P D,et al.Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66(2):115-132.
|
[2] |
余建洪,朱晓丽. ROC曲线评价4项指标对肺癌的鉴别诊断价值[J]. 检验医学与临床,2017,14(3):361-363.
|
[3] |
KIM S H,LEE H W,GO S I,et al.Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio(PLT-PLR) in patients with surgically resected non-small cell lung cancer[J]. Oncotarget,2016,7(24):36198-36206.
|
[4] |
ZHANG X,RAN Y.Prognostic role of elevated platelet count in patients with lung cancer:a systematic review and meta-analysis[J]. Int J Clin Exp Med,2015,8(4):5379-5387.
|
[5] |
赵钰,刘占岩,朱丰,等. 肺癌患者PCDH20、VEGF蛋白及其与临床病理指标的关系[J]. 检验医学与临床,2016,13(22):3196-3198.
|
[6] |
SHARMA D,BRUMMEL-ZIEDINS K E,BOUCHARD B A,et al. Platelets in tumor progression:a host factor that offers multiple potential targets in the treatment of cancer[J]. J Cell Physiol,2014,229(8):1005-1015.
|
[7] |
方慢,罗以勤. 血小板参数在肺癌患者化疗预后评价中的意义[J]. 安徽医科大学学报,2016,51(12):1821-1824.
|
[8] |
雷鸣,杨丽,胡太华,等. 非小细胞肺癌远处转移与血小板参数变化的相关性分析[J]. 国际检验医学杂志,2015,36(6):729-730.
|
[9] |
DIEM S,SCHMID S,KRAPF M,et al.Neutrophil-to-lymphocyte ratio(NLR) and platelet-to-lymphocyte ratio(PLR) as prognostic markers in patients with non-small cell lung cancer(NSCLC) treated with nivolumab[J]. Lung Cancer,2017,111:176-181.
|
[10] |
DENG M,MA X,LIANG X,et al.Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?[J]. Oncotarget,2017,8(23):37200-37207.
|
[11] |
OHUCHI M,INOUE S,OZAKI Y,et al.Platelet count and mean platelet volume are associated with not only bone,soft tissue,and lymph node metastases but also with malignant pleural effusion in lung cancer patients[J]. Neoplasma,2017,64(1):140-147.
|
[12] |
王海燕,钟田花,卢春敏,等. 血小板参数在乳腺癌患者早期诊断中的价值[J]. 重庆医学,2017,46(6):780-781.
|